Skip to main content
OpenTrials
Completed

NCT Number: NCT02571010

Evaluation of the Efficacy of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia

This study aims to demonstrate that somatosensory rehabilitation of pain associated with static mechanical allodynia has superior efficacy over placebo treatment as well as over spontaneous changes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CRRF La Chataigneraie Convention

Paris, Île-de-France Region, 75015, France

About this study

This is a monocenter study. 45 patients will be enrolled in the study, allocated by randomization in 3 arms of 15 patients each.

During the 38 week duration of the study, enrolled patients will be assessed at:

  • initial evaluation (first week of the study),
  • intermediary evaluation for every week and every modification of intensity of pain,
  • final evaluation at 10 weeks,
  • follow-up evaluation at 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Eligibility Criteria

  • Male or female patients aged ≥18 years;
  • Static mechanical allodynia for less than 3 months, whatever its etiology and topography;
  • Probable peripheral or central neuropathic pain or defined according to the IASP criteria;
  • Neuropathic pain diagnostic questionnaire DN4 score ≥ 4/10;
  • Chronic pain with average intensity ≥ 4/10;
  • Analgesic treatment unchanged within 15 days prior to screening, and not planned to be modified during the study;
  • Patient who can attend follow-up visits during the study;
  • Patient affiliated to a health insurance plan or entitled;
  • Patient must be able to give informed consent in accordance with ICH GCP guidelines and local legislation and/or regulations.

Exclusion criteria

  • Patient with neuralgia (spontaneous pain) with or without allodynia;
  • Patient not able to participate actively to the rehabilitation exercises for physical reason, cognitive reason (ability to understand instructions) or behavioural reason (e.g. addiction...);
  • Patient with complex regional pain syndrome (type I);
  • Patients for whom cares cannot avoid any touch with allodynia area;
  • Patient previously treated by a transcutaneous electrical nerve stimulation (TENS);
  • Prior treatment by somatosensory rehabilitation;
  • Duration of stay in the medical center < 11 weeks;
  • Patient with cognitive disorder;
  • Allodynia area of the patient presenting with conditions not recommended for vibrotactile stimulation: wound, unhealed nerve suture, recent skin transplantation, fragile organ such as eye.

Treatment and study plan

Standard Medical Treatment

Other

Standard treatment with drugs and usual rehabilitation

Vibrotactile Stimulation

Device

Rehabilitation by vibrotactile stimulation at medical center

Sham Stimulation with Vibradol device switched off

Device

Sham Rehabilitation at medical center but with Vibradol device switched off

Primary outcomes

  1. Change of baseline in reduction of surface of allodynia area

    Time frame: At baseline, each week during the 10 week treatment period and at 6 months

    Evaluate by the 15 g mono filament (Allodynographie) the reduction of surface of allodynia area

Secondary outcomes

  1. Change of baseline in reduction of pain

    Time frame: At baseline, at each week, at 10 weeks and at 6 months

    Reduction of pain will be evaluated by QDSA questionnaire.

  2. Change of baseline in reduction of allodynia intensity

    Time frame: At baseline, at each week, at 10 weeks and at 6 months

    Reduction of allodynia intensity will be measured with the method with the colors

  3. Change of baseline of patient's satisfaction with regard to received care

    Time frame: At baseline, at each week, at 10 weeks and at 6 months

    Patient's satisfaction with regard to pain relief will be evaluated by VAS

  4. Analgesics consumption

    Time frame: At 6 months

    Amount of analgesic drugs

  5. Afterglow effect

    Time frame: At 6 months

    An evaluation of static mechanical allodynia in surface and intensity at 6 months

Sponsors and collaborators

Lead sponsor

CRRF La Châtaigneraie

Other

Collaborators

  • Hôpitaux Universitaires Paris Ile-de-Franc Ouest

Registry information

Official study title

Pilot Study to Evaluate the Effectiveness of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia of Less Than Three Months Duration

Acronym: RESISTAL

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Oct 8, 2015
Registry last updated
Nov 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.